Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$309K Sell
7,638
-5,123
-40% -$229K 0.01% 780
2026
Q2
$595K Buy
12,761
+806
+7% +$37.3K 0.02% 551
2026
Q1
$586K Buy
11,955
+203
+2% +$9.44K 0.03% 512
2025
Q4
$512K Sell
11,752
-1,299
-10% -$59.3K 0.02% 541
2025
Q3
$587K Buy
13,051
+1
+0% +$44 0.04% 346
2025
Q2
$567K Buy
13,050
+1,670
+15% +$74.4K 0.04% 332
2025
Q1
$524K Buy
11,380
+338
+3% +$14.1K 0.05% 323
2024
Q4
$416K Buy
11,042
+1,798
+19% +$69.7K 0.03% 384
2024
Q3
$375K Buy
+9,244
New +$348K 0.03% 407

Other funds holding EXC

BFC Planning's EXC Position: Q3 2026 in Review

BFC Planning reduced its Exelon (EXC) stake by 40% in Q3 2026, selling an estimated $229K and leaving 7,638 shares worth $309K. The position accounts for 0.01% of the portfolio, ranked #780.

BFC Planning first reported a position in EXC in Q3 2024 and has held it in 9 quarters since. The position peaked at $595K in Q2 2026. 1,072 funds tracked by Wall St. Rank hold EXC as of Q3 2026.

  • BFC Planning held 7,638 shares of Exelon worth $309K as of Q3 2026.
  • BFC Planning sold 5,123 Exelon shares in Q3 2026, an estimated $229K.
  • Exelon made up 0.01% of BFC Planning's portfolio in Q3 2026, its #780 holding.
  • BFC Planning first reported a position in Exelon in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's Exelon position peaked at $595K in Q2 2026.
  • 1,072 funds tracked by Wall St. Rank held Exelon as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.